Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of AMG900-treated LUAD cells

ABSTRACT: RNA sequencing of AMG900-treated LUAD cells

PROVIDER: PRJNA701683 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA sequencing of 53 early stage lung adenocarcinoma and AMG900-treated LUAD cells

Project description:RNA sequencing of 53 early stage lung adenocarcinoma and AMG900-treated LUAD cells

| PRJNA701682 | ENA

Response of LUAD cells to LCS3

Project description:Response of LUAD cells to LCS3

| PRJNA738470 | ENA

RNAseq of combined LUAD and SCLC tumors to look at gene expression changes

Project description:For in-depth characterization of neuroendocrine transformation, we analyzed clinical specimens consisting of combined lung adenocarcinoma (LUAD)/small cell lung carcinoma (SCLC) histology exhibiting clear spatial separation. Microdissection was performed for RNA sequencing.

2021-06-03 | E-MTAB-10399 | biostudies-arrayexpress

Circ101093 regulated proteins in Lung carcinoma (LUAD) cells.

Project description:Circ101093 was knocked down in A549 LUAD cell lines, and overexpressed in H1975 LUAD cell lines. Then, downregulated proteins in A549 cell lines and upregulated proteins in H1975 cell lines were analyzed.

2022-05-20 | PXD025491 | Pride

RNA-Sequencing of HepG2 cells treated with TGFBeta

Project description:RNA-Sequencing of HepG2 cells treated with TGFBeta

| PRJNA578102 | ENA

RNA sequencing of AMG900-treated LUAD cells

Project description:From RNAseq analysis of 53 esLUAD, we identified a gene signature distinguishing invasive and indolent tumors. Regulatory network analysis identified aurora kinases as master regulators of the gene signature. So we applied an aurora kinase pan inhibitor, AMG900, using A549 and H1792 cells to confirm whether the expression of pro-invasive genes were impacted by aurora kinase activity suppression.

2022-02-01 | GSE166721 | GEO

Response of LUAD cells to LCS3

Project description:High-throughput phenotype-based screening of large libraries of compounds can identify small molecules that elicit a desired cellular response, but additional approaches are required to find and characterize their targets and mechanisms of action. Here we show that a compound termed lung cancer screen 3 (LCS3), previously selected for its ability to impair the growth of human lung adenocarcinoma (LUAD) cell lines, but not normal lung cells, induces oxidative stress and activates the NRF2 signaling pathway by generating reactive oxygen species (ROS) in sensitive LUAD cell lines. To identify the effector that mediates this effect, we applied thermal proteome profiling (TPP) and uncovered the disulfide reductases GSR and TXNRD1 as LCS3 targets. Through enzymatic assays using purified protein, we confirmed that LCS3 inhibits disulfide reductase activity through a reversible, uncompetitive mechanism. Further, we demonstrate that LCS3-sensitive LUAD cells are correspondingly sensitive to the synergistic inhibition of glutathione and thioredoxin pathways. Lastly, a genome-wide CRISPR screen identified the loss of NQO1 as a mechanism of LCS3 resistance. This work highlights the power of TPP to uncover targets of small molecules identified by high-throughput screens and demonstrates the potential utility of inhibiting disulfide reductases in treatment of LUAD.

2022-03-02 | GSE178311 | GEO

Transcriptional profiling of p53 mutants in KP LUAD cells

Project description:Transcriptional profiling of KP LUAD cells expressing a panel of p53 mutant cDNAs.

2020-03-18 | GSE136295 | GEO

RNA sequencing of control and DAC-treated CT26 cells.

Project description:RNA sequencing of control and DAC-treated CT26 cells.

| PRJNA793010 | ENA

RNA-seq of Bafilomycin-treated cells

Project description:RNA-seq of Bafilomycin-treated cells

| PRJNA632634 | ENA